X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (570) 570
Book Review (162) 162
Book / eBook (29) 29
Publication (29) 29
Newsletter (9) 9
Magazine Article (5) 5
Book Chapter (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (531) 531
humans (432) 432
male (261) 261
animals (243) 243
diabetes (207) 207
female (180) 180
endocrinology & metabolism (169) 169
rats (128) 128
diabetes mellitus, type 2 - drug therapy (126) 126
middle aged (116) 116
risk factors (115) 115
diabetic angiopathies - prevention & control (112) 112
aged (108) 108
hypoglycemic agents - adverse effects (107) 107
hypoglycemia - chemically induced (95) 95
diabetic angiopathies - chemically induced (94) 94
diabetes mellitus, type 2 - complications (93) 93
diabetes mellitus (91) 91
hypoglycemic agents - therapeutic use (91) 91
diabetic angiopathies - drug therapy (88) 88
diabetic angiopathies - physiopathology (86) 86
type 2 diabetes (76) 76
oxidative stress (75) 75
complications (72) 72
diabetic angiopathies - etiology (69) 69
adult (68) 68
streptozocin (66) 66
abridged index medicus (64) 64
blood glucose - metabolism (61) 61
diabetes mellitus, type 2 - blood (61) 61
diabetic angiopathies - epidemiology (60) 60
insulin (60) 60
diabetes complications (58) 58
mellitus (55) 55
insulin - adverse effects (54) 54
mice (53) 53
diabetes mellitus, experimental - chemically induced (50) 50
diabetic angiopathies - blood (50) 50
diabetic angiopathies - metabolism (50) 50
glucose (50) 50
risk (50) 50
hyperglycemia (49) 49
diabetic angiopathies - pathology (48) 48
mortality (48) 48
insulin - therapeutic use (44) 44
medicine, general & internal (44) 44
cardiac & cardiovascular systems (43) 43
research (43) 43
analysis (42) 42
diabetic angiopathies - complications (42) 42
hypoglycemic agents - administration & dosage (42) 42
atherosclerosis (41) 41
cardiovascular disease (40) 40
cardiovascular diseases - prevention & control (40) 40
disease models, animal (40) 40
pharmacology & pharmacy (40) 40
rats, sprague-dawley (38) 38
treatment outcome (38) 38
physiological aspects (37) 37
cardiovascular diseases (35) 35
health aspects (35) 35
diabetic retinopathy (34) 34
diabetics (34) 34
medicine & public health (34) 34
blood glucose - analysis (33) 33
glycemic control (33) 33
rats, wistar (33) 33
blood glucose - drug effects (32) 32
care and treatment (32) 32
hypoglycemia (32) 32
cardiovascular diseases - epidemiology (31) 31
diabetes mellitus, type 1 - complications (31) 31
peripheral vascular disease (31) 31
diabetes mellitus, experimental - complications (30) 30
diabetes mellitus, type 1 - drug therapy (30) 30
diabetic angiopathies (30) 30
therapy (30) 30
time factors (30) 30
diabetes mellitus, experimental - drug therapy (29) 29
diabetes mellitus, experimental - physiopathology (29) 29
diabetic angiopathies - mortality (28) 28
cardiovascular diseases - chemically induced (27) 27
diabetes mellitus - drug therapy (27) 27
diabetes therapy (27) 27
glycation end products, advanced - metabolism (27) 27
hypertension - drug therapy (27) 27
internal medicine (27) 27
rodents (27) 27
biomarkers - blood (26) 26
diabetes mellitus, type 1 - blood (26) 26
diabetes mellitus, type 2 - physiopathology (26) 26
glycated hemoglobin a - metabolism (26) 26
hypertension (26) 26
myocardial-infarction (26) 26
randomized controlled trials as topic (26) 26
cardiovascular-disease (25) 25
disease (25) 25
dose-response relationship, drug (25) 25
expression (25) 25
physiology (25) 25
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (568) 568
German (14) 14
French (11) 11
Italian (3) 3
Japanese (3) 3
Russian (3) 3
Spanish (3) 3
Swedish (3) 3
Polish (2) 2
Romanian (2) 2
Czech (1) 1
Finnish (1) 1
Hungarian (1) 1
Portuguese (1) 1
Romansh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2018, Volume 20, Issue 5, pp. 1102 - 1110
Aim: To describe the baseline characteristics of participants randomized in the Dapagliflozin Effect on CardiovascuLAR Events (DECLARE-TIMI 58) trial, the... 
inhibitors | cardiovascular outcomes | CVOTs | type 2 diabetes | SGLT2 | dapagliflozin | SGLT2 inhibitors | METFORMIN | PLACEBO | 2 INHIBITORS | INADEQUATE GLYCEMIC CONTROL | BLOOD-PRESSURE | ADD-ON THERAPY | BODY-WEIGHT | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | TYPE-2 DIABETES-MELLITUS | Metformin - therapeutic use | Prevalence | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Cardiovascular Diseases - complications | Clinical Trials, Phase III as Topic | Drug Therapy, Combination - adverse effects | Benzhydryl Compounds - adverse effects | Multicenter Studies as Topic | Cardiovascular Diseases - epidemiology | Diabetic Cardiomyopathies - prevention & control | Female | Glucosides - therapeutic use | Diabetic Angiopathies - prevention & control | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Body Mass Index | Hypoglycemic Agents - therapeutic use | Diabetic Angiopathies - chemically induced | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Double-Blind Method | Obesity - complications | Risk Factors | Diabetic Cardiomyopathies - epidemiology | Diabetic Angiopathies - epidemiology | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Cardiomyopathies - chemically induced | Insulin - therapeutic use | Cohort Studies | Type 2 diabetes | Hypertension | Glycosylated hemoglobin | Aspirin | Statins | Diabetes mellitus | Insulin | Patients | Risk factors | Body mass index | Arteriosclerosis | Hemoglobin | Clopidogrel | Diabetes | Metformin | Diabetes mellitus (non-insulin dependent) | Smoking | Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 07/2013, Volume 15, Issue 7, pp. 668 - 673
Aim As there have been concerns that some classes or agents for the treatment of type 2 diabetes may increase CV risk, we evaluated the cardiovascular profile... 
cardiovascular disease | type 2 diabetes | DPP‐IV | inhibitor | Type 2 diabetes | Cardiovascular disease | DPP-IV inhibitor | METFORMIN | MONOTHERAPY | GLP-1 | EFFICACY | INADEQUATE GLYCEMIC CONTROL | PIOGLITAZONE | GLUCOSE | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | THERAPIES | OUTCOMES | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Male | Diabetic Cardiomyopathies - physiopathology | Incidence | Cardiovascular Diseases - complications | Diabetic Angiopathies - physiopathology | Cardiovascular Diseases - epidemiology | Female | Diabetes Mellitus, Type 2 - complications | Severity of Illness Index | Diabetic Angiopathies - chemically induced | Cardiovascular Diseases - physiopathology | Double-Blind Method | Proportional Hazards Models | Uracil - therapeutic use | Uracil - adverse effects | Piperidines - therapeutic use | Diabetic Cardiomyopathies - epidemiology | Piperidines - adverse effects | Diabetic Angiopathies - epidemiology | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Cardiomyopathies - chemically induced | Cohort Studies | Uracil - analogs & derivatives | Hypoglycemic agents | Safety and security measures | Analysis | Heart attack | Confidence intervals | Medical research | Heart attacks | Diabetes | Index Medicus
Journal Article
by Leiter, L. A and Lundman, P and da Silva, P. M and xel, H and Jünger, C and Gitt, A. K and Absenger, Guun and Albrich, Ernst and Allinger, Berndt and Allinger, Stephan and Anacher, Gerald and Angermayr, Gertraud and Angermeier, Hermann and Anzengruber, Aneas and Archimanitis, Gabriele and Arnsteiner, Patricia and Auberger, Wolfgang and Azhary, Mawaheb and Barfuss, Michael and Bauer, Christian and Bauer, Birgit Elisabeth and Beclin, Thomas and Binder, Thomas and Binder, Gabriele and Böhler, Dietmar and Brändle, Johann and Breslmair, Jörg and Brettlecker, Marlis and Bürger, Michael and Calvi, Inge and Dorfinger, Werner and Doringer-Schnepf, Elisabeth and Eer, Anton and Eckmayr, Christine and Eder, Franz and Egermann, Margit and Erath, Michael and Etzinger, Michael and Etzinger, Claudia and Fiedler, Lothar and Filip, Wolfgang and Filip, Michaela and Föchterle, Johann and Fodor, Anita and Frieden, Thomas and Gareiss, Mertens and Gföllner, Peter and Ghamarian, Thomas and Goritschan, Michael and Haar, Klaus and Habeler, Gerhard and Hadjiivanov, Valery and Haiböck, Christian and Hammer, Regina and Hartmann, Siegfried and Haschkovitz, Herbert and Hauer, Walter and Hauer, Josef and Haunschmidt, Christian and Heimayr, Christine and Hengl, Wolfgang and Hengl, Gunter and Hermann, Rudolf and Herrmann, Rainer and Hillebrand, Roswitha and Hintersteininger, Otto and Hirsch, Michael and Hitzinger, Martin and Hochegger, Tanja and Hockl, Wolfgang and Hoi, Michael and Hörmann, Jan and Hudler, Brigitte and Imb, Gerhard and Joichl, Anea and Jungbauer, Karl and Kapl, Gerlinde and Kerschbaum, Margit and Kienesberger, Franz and Killinger, Gerhard and Kitzler, Gerhard and Klein, Franz and Kleinbichler, Dietmar and Kohr, Anton and Kopetzky, Michael and Korthals, Christian and Kortschak, Werner and Koschutnik, Martin and Kraus, Werner A and Kurzemann, Susanne and Lavicka, Claus and Lehner, Guido and Lenz, Jürgen and Lepuschütz, Sabine and Lichtenwallner, Michael and Lober, Reinhard and Loidl, Christine and Lopatka, Eduard and Ludwig, Rudolf and Maca, Thomas and ... and DYSIS Investigators and DYSIS investigators
Diabetic medicine, ISSN 0742-3071, 2011, Volume 28, Issue 11, pp. 1343 - 1351
To assess the prevalence of persistent lipid abnormalities in statin-treated patients with diabetes with and without the metabolic syndrome. This was a... 
metabolic syndrome | cardiovascular disease | diabetes mellitus | dyslipidaemia | statins | Cardiovascular disease | Dyslipidaemia | Metabolic syndrome | Diabetes mellitus | Statins | METAANALYSIS | GUIDELINES | PREVENTION | DENSITY-LIPOPROTEIN CHOLESTEROL | THERAPY | REDUCTION | ENDOCRINOLOGY & METABOLISM | CORONARY-HEART-DISEASE | CLINICAL-PRACTICE | CARDIOVASCULAR RISK | LOW HDL-CHOLESTEROL | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Humans | Diabetic Angiopathies - etiology | Male | Metabolic Syndrome - drug therapy | Diabetes Mellitus, Type 2 - epidemiology | Metabolic Syndrome - blood | Canada - epidemiology | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Dyslipidemias - etiology | Diabetes Mellitus, Type 2 - complications | Metabolic Syndrome - epidemiology | Cardiovascular Diseases - etiology | Diabetic Angiopathies - chemically induced | Cross-Sectional Studies | Cholesterol, HDL - drug effects | Europe - epidemiology | Cholesterol, LDL - drug effects | Diabetic Angiopathies - blood | Anticholesteremic Agents - adverse effects | Metabolic Syndrome - complications | Diabetes Mellitus, Type 2 - blood | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Anticholesteremic Agents - administration & dosage | Dyslipidemias - chemically induced | Cholesterol, HDL - blood | Diabetic Angiopathies - epidemiology | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Diabetics | Blood cholesterol | Simvastatin | Low density lipoproteins | Triglycerides | Diabetes | Risk factors | Trans fatty acids | Index Medicus
Journal Article